Equities Research Analysts’ updated eps estimates for Friday, January 12th:

adidas (FRA:ADS) was given a €198.00 ($235.71) price target by analysts at Nord/LB. The firm currently has a neutral rating on the stock.

Banner (NASDAQ:BANR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $65.00 target price on the stock. According to Zacks, “Banner Corporation is a bank holding company operating two commercial banks in five Western states through a network of branches offering a full range of deposit services and business, commercial real estate, construction, residential, agricultural and consumer loans. “

Bellicum Pharmaceuticals (NASDAQ:BLCM) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It is focused on discovering and developing cellular immunotherapies for various forms of cancer, including both hematological and solid tumors, as well as orphan inherited blood disorders. The Company’s lead clinical product candidate is BPX-501, an adjunct T-cell therapy in multiple Phase I/II clinical trials. It is also developing BPX-201, a dendritic cell cancer vaccine, which is in a Phase I clinical trial for the treatment of metastatic castrate-resistant prostate cancer. Bellicum Pharmaceuticals, Inc. is based in Houston, Texas. “

TopBuild (NYSE:BLD) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “TopBuild Corp. is the installer and distributor of insulation products to the construction industry primarily in the United States. The company also installs and distributes other building products, which consists of rain gutters, garage doors, fireplaces, shower enclosures, closet shelving and roofing. It offers insulation installation services. TopBuild Corp. TopBuild Corp. is headquartered in Daytona Beach, FL. “

BofI (NASDAQ:BOFI) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $37.00 target price on the stock. According to Zacks, “Bofi Holding is the holding company for Bank of Internet USA, a consumer-focused, nationwide savings bank operating primarily through the Internet from a single location in San Diego, California. They provide a variety of consumer banking services, focusing primarily on gathering retail deposits over the Internet and originating and purchasing multifamily and single family loans for investment. “

Hugo Boss (ETR:BOSS) was given a €88.00 ($104.76) target price by analysts at Nord/LB. The firm currently has a buy rating on the stock.

The Bank of Princeton (NASDAQ:BPRN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “The Bank of Princeton is a community bank which provides banking products and services. The company offers checking accounts, savings accounts, attorney trust accounts, money market accounts and certificates of deposit; and commercial real estate, commercial and industrial, construction, residential first-lien mortgage, home equity and consumer loans, as well as lines of credit. It operates primarily in New Jersey, Hamilton, Pennington, Montgomery, Monroe Township, Lambertville, New Brunswick, Lawrenceville. The Bank of Princeton is headquartered in Princeton, New Jersey. “

BioSpecifics Technologies (NASDAQ:BSTC) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (FDA) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals. “

BioTime (NYSEAMERICAN:BTX) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “BioTime, Inc. is a clinical-stage biotechnology company focused on developing and commercializing novel therapies in the field of regenerative medicine. The foundation of its core therapeutic technology platform is pluripotent cells that are capable of becoming any of the cell types in the human body. BioTime’s research and other activities have resulted, over time, in the creation of other subsidiaries that address other non-therapeutic market opportunities such as cancer diagnostics, drug development and cell research products, and mobile health software applications. “

Byline Bancorp (NYSE:BY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $25.00 target price on the stock. According to Zacks, “Byline Bancorp, Inc. operates as a bank holding company serving small- and medium-sized businesses, financial sponsors and consumers. The Company offers saving accounts, credit cards, loans, mortgages, lending, equipment leasing, cash management and online banking services. Byline Bancorp, Inc. is headquartered in Chicago, Illinois. “

Bunzl (OTCMKTS:BZLFY) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $31.00 price target on the stock. According to Zacks, “Bunzl Plc operates in two business areas; Outsourcing Services and Filtrona. As an international componay Bunzl has developed sound partnerships with both suppliers and customers by providing outsourcing solutions and customer service oriented distribution and light manufacture, primarily of plastic and paper based products. “

Credit Acceptance (NASDAQ:CACC) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. The firm currently has $390.00 price target on the stock. According to Zacks, “Credit Acceptance Corporation is a specialized financial services company which provides funding, receivables management, collection, sales training and related services to automobile dealers. “

CrossAmerica Partners (NYSE:CAPL) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CrossAmerica Partners LP engages in the wholesale distribution of motor fuels, consisting of gasoline and diesel fuel, and owns and leases real estate used in the retail distribution of motor fuels. CrossAmerica Partners LP, formerly known as Lehigh Gas Partners LP, is headquartered in Allentown, Pennsylvania. “

Meta Financial Group (NASDAQ:CASH) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. They currently have $119.00 target price on the stock. According to Zacks, “Meta Financial Group, Inc. is the holding company for federally chartered savings bank MetaBank, Member FDIC. Headquartered in Sioux Falls, S.D., MetaBank operates in both the Banking and Payments industries: MetaBank, its retail banking division; Meta Payment Systems, its electronic payments division; AFS/IBEX, its insurance premium finance division; and Refund Advantage, its tax refund-transfer software division. The synergies among the four provide a unique business model for the company. “

Fiserv (NASDAQ:FISV) was given a $148.00 price target by analysts at Argus. The firm currently has a buy rating on the stock.

Gerry Weber International (ETR:GWI1) was given a €20.00 ($23.81) target price by analysts at Nord/LB. The firm currently has a buy rating on the stock.

Henkel AG & Co KGaA (FRA:HEN3) was given a €112.00 ($133.33) price target by analysts at Nord/LB. The firm currently has a neutral rating on the stock.

JPMorgan Chase & Co. (NYSE:JPM) had its price target raised by Argus from $109.00 to $125.00. Argus currently has a buy rating on the stock.

Receive News & Ratings for adidas AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for adidas AG and related companies with MarketBeat.com's FREE daily email newsletter.